BrainsWay Ltd.
NASDAQ:BWAYMedical - Devices
+$0.05 today
- Market cap
- $352.22M
- Beta
- 0.15
- P/E (TTM)
- 61.7
- EPS (TTM)
- $0.23
Volume 0.15M
Average 0.15M
BWAY Free Cash Flow
Operating cash flow minus capital expenditures: cash available for debt repayment, dividends, and buybacks.
BrainsWay Ltd.NASDAQ: BWAY
Free Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Free cash flow dips below year-ago levels
Q1 FY2026 free cash flow of $402K fell 89.9% year over year, behind the +58.7% change in trailing-twelve-month free cash flow. Sequentially, it fell 22.5% from the prior quarter.
Context
- Free cash flow amounted to 31.4% of revenue in FY2025, up 15.5 pp from a year earlier.
- Free cash flow increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -89.9% toward the trailing-twelve-month pace of +58.7%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Free Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 16.4M USD
- Year-over-year change
- +152.2%
| Period | Period end | Free Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 16.4M | +152.2% |
| FY2024 | 2024-12-31 | 6.5M | +689.7% |
| FY2023 | 2023-12-31 | (1.1M) | +88.7% |
| FY2022 | 2022-12-31 | (9.76M) | -620.8% |
| FY2021 | 2021-12-31 | (1.35M) | — |
Free Cash Flow vs competitors
How BWAY compares with its peers on the latest reported figures
- BWAY's LTM Mar 2026 free cash flow of $12.72M is the 3rd largest of the 4 companies compared; the peer median is $13.58M.
- Its year-over-year change of +58.7% is the highest of 4, against a peer median of -45.8%.
- Free cash flow amounts to 22.6% of revenue for BWAY, versus a peer median of 9.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $17.81M | +53.8% | +62.3% | 185.7% | |
| LTM Mar 2026 | $13.58M | -63.6% | -14.6% | 9.0% | |
| LTM Mar 2026 | $12.72M | +58.7% | — | 22.6% | |
| LTM Mar 2026 | $9.84M | -45.8% | -32.9% | 9.9% | |
MOBIMobia Medical, Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding BWAY) | $13.58M | -45.8% | -14.6% | 9.9% | |
Competitors are the stored peer set for BWAY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (6.46M) | (13.35M) | (4.2M) | 2.92M | 7.63M |
| Depreciation & Amortization | 1.69M | 1.53M | 1.34M | 1.77M | 1.54M |
| Deferred Income Tax | 43K | 315K | 251K | 538K | 77K |
| Stock-Based Compensation | 1.89M | 1.47M | 381K | 1.44M | 1.2M |
| Change in Working Capital | 1.07M | (1.45M) | 1.64M | 2.39M | 8.23M |
| Accounts Receivables | (849K) | 1.46M | 1.09M | (867K) | 611.82K |
| Inventory | (411K) | (3.6M) | (506K) | (920K) | (1.41M) |
| Accounts Payables | 289K | 0 | (327K) | 2.12M | (480.78K) |
| Other Working Capital | 2.04M | 685K | 1.38M | 2.06M | 9.52M |
| Other Non-Cash Items | 2.66M | 1.72M | 1.88M | 1.24M | (506.79K) |
| Operating Cash Flow | 884K | (9.76M) | 1.28M | 10.3M | 18.16M |
| Capital Expenditures | (2.24M) | 9.72M | (2.39M) | (3.79M) | (1.76M) |
| Acquisitions (Net) | 39.98M | 0 | 0 | 0 | 0 |
| Purchases of Investments | (40M) | (21K) | 0 | 0 | (15.89M) |
| Sales of Investments | 22K | 40.25M | 0 | 0 | 20.16K |
| Other Investing Activities | (39.98M) | 0 | (35.02M) | 35.08M | 0 |
| Investing Cash Flow | (42.22M) | 42.17M | (37.41M) | 30.31M | (17.63M) |
| Debt Repayment | (475K) | (533K) | (271K) | (424K) | (832K) |
| Common Stock Issued | 42.26M | 0 | 0 | 16.35M | 0 |
| Common Stock Repurchased | 0 | (52K) | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (269K) | (962K) | (755K) | 2.33M | (1.4M) |
| Financing Cash Flow | 41.52M | (1.55M) | (1.03M) | 18.26M | (2.23M) |
| Effect of Forex Changes | (224K) | (202K) | 90K | (47K) | 34.35K |
| Net Change in Cash | (40K) | 30.66M | (37.06M) | 58.83M | (1.67M) |
| Free Cash Flow | (1.35M) | (9.76M) | (1.1M) | 6.5M | 16.4M |
BrainsWay Ltd.
NASDAQ:BWAY
Intrinsic Alpha fair value
Locked
Current Price
$8.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.